Gritstone Bio Inc (GRTS)
0.7465
0.00 (0.00%)
USD |
NASDAQ |
Apr 18, 16:00
0.7465
0.00 (0.00%)
After-Hours: 20:00
Gritstone Bio Total Assets (Quarterly): 177.77M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 177.77M |
| September 30, 2023 | 187.22M |
| June 30, 2023 | 222.62M |
| March 31, 2023 | 209.95M |
| December 31, 2022 | 240.75M |
| September 30, 2022 | 205.24M |
| June 30, 2022 | 213.95M |
| March 31, 2022 | 243.47M |
| December 31, 2021 | 278.11M |
| September 30, 2021 | 271.28M |
| June 30, 2021 | 224.22M |
| March 31, 2021 | 246.94M |
| Date | Value |
|---|---|
| December 31, 2020 | 221.57M |
| September 30, 2020 | 122.51M |
| June 30, 2020 | 145.67M |
| March 31, 2020 | 163.02M |
| December 31, 2019 | 184.39M |
| September 30, 2019 | 208.65M |
| June 30, 2019 | 228.18M |
| March 31, 2019 | 175.49M |
| December 31, 2018 | 189.56M |
| September 30, 2018 | 113.20M |
| June 30, 2018 | 95.95M |
| December 31, 2017 | 117.30M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
122.51M
Minimum
Sep 2020
278.11M
Maximum
Dec 2021
210.29M
Average
213.95M
Median
Jun 2022
Total Assets (Quarterly) Benchmarks
| Precision BioSciences Inc | 159.78M |
| Humacyte Inc | 128.22M |
| Verastem Inc | 149.72M |
| BioVie Inc | 21.49M |
| Syros Pharmaceuticals Inc | 168.17M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 125.92M |
| Shareholders Equity (Quarterly) | 51.85M |
| Debt to Equity Ratio | 0.7742 |
| Current Ratio | 3.198 |
| Net Debt Paydown Yield | -2.10% |